“Hormonal Acne: Causes, Patterns, and How to Treat It”

Hormonal acne is acne driven by androgens and by monthly shifts in estrogen, progesterone, insulin and cortisol, and it usually shows up as deep, tender breakouts along the jawline, chin and lower cheeks that flare in the week before a period. The American Academy of Dermatology's 2024 acne guidelines (Reynolds and colleagues) list combined oral contraceptives and spironolactone among the recommended treatments for women, with topical retinoids, diet changes and a check for PCOS shaping the rest of the plan [15].

The Pattern That Gives It Away

Hormonal acne has a signature. It tends to concentrate on the lower third of the face: the chin, jawline, and sides of the neck. Breakouts are often deeper and more painful than typical comedonal acne, showing up as cysts or tender papules rather than surface-level blackheads.

There is usually a timing element too: flares that track reliably with the menstrual cycle, appearing around ovulation or in the week before menstruation and clearing up once the period begins. Dermatologists often call this premenstrual acne flare or cyclical acne.

This pattern affects women across a wide age range. Adult female acne, broadly defined as acne persisting or appearing after age 25, affects around 26% of women in their 30s and 12% in their 40s [1]. It is common, often undertreated, and frequently mismanaged with the same approaches used for teenage acne, which do not address the underlying hormonal driver.

Men can also experience hormonally driven acne, particularly during puberty, with anabolic steroid use, or when testosterone replacement therapy (TRT) causes sebum overproduction. But the condition disproportionately affects adult women, and most of what follows applies specifically to them. The broader picture of acne as a condition, including teenage and comedonal acne, sits on its own page.

Hormonal Acne vs. Regular Acne: How to Tell the Difference

Hormonal acne and adolescent acne vulgaris share the same four mechanisms: excess sebum, clogged pores, Cutibacterium acnes overgrowth and inflammation. What separates them is location, lesion type, timing and how they respond to standard treatment.

Several conditions look like hormonal acne but need different treatment. Rosacea causes flushing and bumps without blackheads, perioral dermatitis clusters around the mouth and nose, and Malassezia (fungal) folliculitis produces itchy, uniform bumps that antibiotics can worsen. A dermatologist distinguishes these on examination, which is why a diagnosis comes before a hormonal treatment plan.

For the full list of acne triggers beyond hormones, including genetics, friction and medications, see the science behind what causes breakouts.

How Hormones Drive Acne

The Role of Androgens

Androgens are the primary hormonal driver of acne. Testosterone, dehydroepiandrosterone sulfate (DHEAS), and dihydrotestosterone (DHT) all stimulate sebaceous glands to produce more sebum. More sebum means more substrate for Cutibacterium acnes bacteria to feed on and more opportunity for pores to become blocked.

The relationship between androgens and acne is not simply about having high testosterone levels. Sebaceous glands are sensitive to even normal circulating androgen levels, and the sensitivity of those glands varies between individuals. This is why many women with hormonal acne have lab values that fall within the normal range: the problem is often at the receptor level or in the local conversion of androgen precursors to DHT within the skin itself [2].

The enzyme 5 alpha reductase performs that local conversion inside the sebaceous gland. Its activity explains why two women with identical blood tests can have very different skin, and why treatments that block the androgen receptor itself, such as spironolactone and clascoterone, can work when lab results look normal.

The Menstrual Cycle Connection

Estrogen and progesterone fluctuate across the menstrual cycle in ways that directly influence skin. Estrogen has anti-androgenic properties and reduces sebum production. Progesterone, particularly in its metabolized form, can have pro-androgenic effects on sebaceous glands.

During the luteal phase (the second half of the cycle, after ovulation), progesterone peaks while estrogen drops. This relative shift toward androgens triggers increased sebum production in the days before menstruation. Combined with the fact that skin permeability and inflammation also increase during this phase, it creates conditions ripe for breakouts [3].

Ovulation itself can also trigger flares in some women. The mid-cycle surge in luteinizing hormone (LH) stimulates androgen production in the ovaries, which can tip sebum production upward for a few days around days 12 to 16 of the cycle.

PCOS and Hyperandrogenism

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting 6 to 12% of the population. Hyperandrogenism, one of the three diagnostic criteria for PCOS, manifests as acne, hirsutism (excess facial and body hair), and androgenic alopecia.

Women with PCOS-related acne often experience breakouts that are more severe and more resistant to conventional treatments than typical hormonal acne. This is because the underlying driver is systemic: elevated androgens from the ovaries and adrenal glands, often combined with insulin resistance that further stimulates androgen production [4]. Treating the acne without addressing the PCOS is treating a symptom while ignoring the cause.

The Rotterdam criteria, used by most gynecologists and endocrinologists, diagnose PCOS when two of three features are present: signs of high androgens, irregular or absent ovulation, and polycystic ovaries on ultrasound. A woman can have PCOS without cysts, so jawline acne plus irregular cycles is reason enough to ask. The complete guide to PCOS covers the diagnosis in more depth.

Insulin and IGF-1

Insulin and insulin-like growth factor-1 (IGF-1) are less talked about but meaningfully contribute to hormonal acne. Both stimulate sebaceous gland activity and promote the production of androgens in the ovaries and adrenal glands. Diets high in refined carbohydrates and dairy products, which raise insulin and IGF-1, are associated with worse acne in multiple epidemiological studies [5].

This connection explains why adult women with insulin resistance, not just those with PCOS, often struggle with persistent breakouts, and why dietary changes can produce noticeable improvements even without changes to their skincare routine.

Cortisol and Stress

Stress-induced acne flares are real and physiologically explained. The adrenal glands produce androgens, including DHEAS, in response to stress, and cortisol amplifies the sebaceous gland’s sensitivity to those androgens. The skin also has its own local HPA-like axis and can produce corticotropin-releasing hormone (CRH) in response to psychological stress, which directly stimulates sebocytes [6].

Assessing Hormonal Acne

When to Get Labs

Not every woman with cyclical jawline acne needs an endocrine workup. But certain signs warrant investigation: acne that is severe or treatment-resistant, breakouts accompanied by irregular periods, hirsutism, significant hair loss, weight gain, or fatigue. In these cases, testing total and free testosterone, DHEAS, LH, FSH, and fasting insulin and glucose can reveal underlying drivers.

Thyroid dysfunction, particularly hypothyroidism, can also contribute to acne through effects on skin cell turnover and sebum composition. TSH testing is worth including in a comprehensive workup for adult women with persistent acne.

What a Hormone Panel Can and Cannot Show

A hormone panel identifies systemic drivers such as PCOS, adrenal androgen excess or insulin resistance. It cannot measure how sensitive the skin's own androgen receptors are, so normal results do not rule out hormonal acne. Timing matters too: many clinicians draw androgen levels in the early follicular phase and ask patients to pause hormonal contraception first, because the pill suppresses the values being measured.

Very high testosterone or DHEAS, rapid onset of hair growth or a deepening voice are different signals. They point toward an androgen-secreting tumor or nonclassic congenital adrenal hyperplasia, which an endocrinologist evaluates before any acne treatment starts.

Treatment Options

Hormonal acne treatment works best when it targets the androgen signal, not only the skin surface. Dermatologists usually combine a hormonal therapy, such as a combined oral contraceptive or spironolactone, with a topical retinoid, and add diet and lifestyle changes where insulin or stress is part of the picture. The table below compares the options this section covers.

Oral Contraceptives

Combined oral contraceptives (estrogen plus progestin) treat hormonal acne through two main mechanisms: they suppress ovarian androgen production via LH suppression, and the estrogen component increases sex hormone-binding globulin (SHBG), which binds free testosterone and reduces its availability to sebaceous glands.

Not all OCPs are equally useful for acne. Pills containing progestins with low androgenic activity or anti-androgenic activity are preferred. Drospirenone (found in Yaz, Yasmin, and generics) and cyproterone acetate (not available in the US but widely used elsewhere) are the best-studied options for acne specifically [7]. Three OCP formulations are FDA-approved for acne treatment: Estrostep, Ortho Tri-Cyclen, and Yaz.

OCPs can take three to six months to show full benefit for acne. They are not appropriate for women who smoke and are over 35, who have a history of blood clots, migraines with aura, or certain cardiovascular risk factors.

Spironolactone

Spironolactone is an aldosterone antagonist originally used for heart failure and hypertension. At lower doses (25 to 150 mg per day), it blocks androgen receptors in the skin and reduces androgen-stimulated sebum production. It has become one of the most commonly used off-label treatments for adult female acne in the United States [8].

Clinical evidence supports its effectiveness. A large retrospective study found that 66% of women treated with spironolactone for acne had at least a 50% reduction in lesion count [9]. It is particularly effective for the cystic, deep breakouts along the jawline and chin that characterize hormonal acne.

Side effects include breast tenderness, irregular periods (often improved by combining with an OCP), and, in higher doses, dizziness. Spironolactone is teratogenic in animal studies, so contraception is recommended during use. Potassium levels should be monitored in women with kidney disease, though routine monitoring is generally considered unnecessary in healthy young women on standard doses [10].

Spironolactone is not FDA approved for acne, so its use here is off label, which is common and legal in US dermatology practice. The 2024 American Academy of Dermatology guidelines include it as an option for women with acne [15]. It is a prescription medicine and is not used in men for acne because of its feminizing effects.

Topical Treatments for Hormonal Acne

Topicals play a supporting role in hormonal acne. A topical retinoid (adapalene, tretinoin) addresses the comedonal component and keeps pores clear. Azelaic acid is particularly useful for women who also deal with post-inflammatory hyperpigmentation, which is common in adult women with deeper skin tones.

Topical clascoterone (Winlevi) is a newer option worth knowing about. It is a topical androgen receptor antagonist that blocks DHT at the level of the sebaceous gland without systemic hormonal effects. In clinical trials, it reduced inflammatory and non-inflammatory acne lesion counts comparably to tretinoin 0.025%, making it an option for women who cannot use or do not want systemic hormonal treatments [11].

Dietary and Lifestyle Approaches

Reducing dietary glycemic load is the most evidence-backed dietary intervention for acne. A randomized controlled trial found that a low-glycemic diet led to significant reductions in acne lesion counts over 12 weeks, alongside reductions in free androgen index [12]. Reducing dairy, particularly skimmed milk (which paradoxically has a higher acne association than whole milk, likely due to whey protein and growth factor content), is also supported by observational data.

For women with PCOS, inositol supplements, particularly myo-inositol at 2 to 4 grams per day, improve insulin sensitivity and reduce androgen levels. Several trials have shown improvements in acne alongside improvements in cycle regularity and hormonal markers [13]. The evidence and dosing are covered in more detail in inositol for PCOS.

Sleep, exercise, and stress management all matter here in ways that are not trivial. Chronic sleep deprivation raises cortisol and insulin, both of which worsen hormonal acne. High-intensity exercise (particularly appropriate amounts, not overtraining) improves insulin sensitivity. And whatever stress management practices a person will actually sustain, whether therapy, meditation, or simply protecting sleep and downtime, has measurable effects on hormonal balance.

Nutraceuticals with Evidence

Zinc, particularly oral zinc gluconate or zinc acetate, has meaningful anti-inflammatory and mild anti-androgenic effects. Multiple trials have shown reductions in acne lesion counts, though it tends to perform less well than oral antibiotics in direct comparisons. It is a reasonable option for women who prefer to minimize pharmaceutical drug exposure [14].

DIM (diindolylmethane), a compound derived from cruciferous vegetables, promotes the metabolism of estrogen toward less potent forms and has a modest influence on androgen metabolism. Clinical evidence for DIM specifically in acne is limited, but it is low-risk and popular in functional medicine settings for hormonally driven skin issues.

How Long Does Hormonal Acne Treatment Take to Work?

Hormonal acne treatments take months, not weeks. Combined oral contraceptives usually need three to six months to reach full benefit, spironolactone is typically judged after several months at a stable dose, and the clascoterone trials measured results at 12 weeks. Skin cells and sebaceous glands turn over slowly, so a fair trial of any one treatment spans at least three menstrual cycles.

Breakouts often return when hormonal treatment stops, because the underlying androgen sensitivity has not changed. Many women stay on a maintenance plan, such as a topical retinoid with or without a lower spironolactone dose, which is a decision to revisit with the prescribing clinician over time.

When Hormonal Acne Is Severe or Scarring

Severe hormonal acne, meaning deep nodules and cysts that leave scars or do not respond to several months of hormonal therapy, usually calls for oral isotretinoin. Isotretinoin shrinks sebaceous glands directly and is the one acne medicine that can produce long remissions after a single course. In the US it is prescribed through the FDA's iPLEDGE program because it causes serious birth defects, so pregnancy testing and two forms of contraception are required during treatment.

Oral antibiotics such as doxycycline are often used for a few months to calm inflammation, but the 2024 AAD guidelines advise limiting their duration and pairing them with benzoyl peroxide to reduce bacterial resistance [15]. Options beyond isotretinoin are reviewed in severe acne treatment beyond Accutane, and scarring is addressed in acne scar treatment.

In-Clinic and Regenerative Options for Hormonal Acne

In-clinic procedures support hormonal acne treatment but do not replace it, because none of them lowers androgen activity. Dermatology practices and medical spas offer chemical peels, blue and red light therapy, photodynamic therapy and laser treatments for active breakouts and post-acne marks. Most are cash pay and are rarely covered by insurance.

Red light therapy, also called low level light therapy or photobiomodulation, is used for its anti-inflammatory effect, and blue light targets C. acnes. Trial results for light therapy in acne are mixed and the studies are small, so it fits best as an add-on to medical treatment. The red light therapy treatment guide covers how the devices work and what the evidence shows, and the regenerated.com acne treatment guide compares conventional and integrative approaches side by side.

Peptide therapies and other regenerative treatments are sometimes marketed for skin, but none has trial evidence specific to hormonal acne. Treat any such offer as experimental and ask the clinic what data supports it for acne specifically.

Who Treats Hormonal Acne?

Board certified dermatologists diagnose and treat hormonal acne, and they prescribe spironolactone, oral contraceptives, clascoterone and isotretinoin. Gynecologists and primary care physicians often manage the hormonal side, especially when acne comes with irregular periods. Endocrinologists evaluate suspected PCOS, adrenal disorders or very high androgen levels, and integrative or functional medicine physicians, naturopathic doctors and nurse practitioners frequently address diet, insulin resistance and stress.

A good first visit covers your cycle history, current medications and supplements, any hair growth or hair loss, and what you have already tried. Ask how the clinician will judge whether a treatment is working and when they would order labs or refer you on.

To compare practices near you, browse acne treatment clinics in the regenerated.com directory. Listing order there is not paid ranking, Featured slots are clearly labeled and capped, Verified means the clinic completed credential checks rather than paid for placement, and the directory is free for patients. Being listed is not an endorsement, so the guide to Featured, Verified and organic listings explains how to read each label.

A Note on Perimenopause and Postmenopausal Acne

Acne during perimenopause is common and often surprises women who expect their skin to clear as they get older. As estrogen levels decline and fluctuate, the relative androgenic effect on sebaceous glands increases. Progesterone loss also removes some of the counterbalancing effects on skin inflammation.

Postmenopausal acne, though less common, does occur. In these cases, the ratio of androgens to estrogen is even more skewed, and low-dose topical estrogens, spironolactone, or retinoids may all play a role in management. A gynecologist or dermatologist familiar with hormonal skin changes is worth consulting for acne that develops or worsens during this transition.

Hormone replacement therapy can change the picture in either direction. Estrogen tends to calm sebum production, while regimens that include testosterone or more androgenic progestins can trigger breakouts. Women starting or adjusting hormone replacement therapy (HRT) who notice new jawline acne should raise it with the prescriber, and broader options for this life stage are covered in the menopause treatment guide.

Frequently asked questions

What does hormonal acne look like?

Hormonal acne looks like deep, tender red bumps and cysts concentrated on the chin, jawline, lower cheeks and sides of the neck. The breakouts often feel sore under the skin before they surface and tend to leave dark marks. Hormonal acne usually flares around ovulation or in the week before a period, then settles once bleeding starts. Blackheads and whiteheads on the forehead and nose point more toward ordinary comedonal acne than a hormonal pattern.

How do I know if my acne is hormonal?

Acne is likely hormonal when it sits on the lower face, flares on a predictable monthly schedule, starts or persists after age 25, and keeps returning despite good topical care. Irregular periods, excess facial or body hair, or scalp hair thinning alongside acne suggest an androgen excess such as PCOS. A dermatologist confirms the pattern on examination and decides whether hormone blood tests, including testosterone, DHEAS and fasting insulin, are worth ordering.

What is the most effective treatment for hormonal acne?

Spironolactone and combined oral contraceptives are the most evidence-backed treatments for hormonal acne in women, and the American Academy of Dermatology's 2024 guidelines include both. In one retrospective study, 66% of women on spironolactone saw lesion counts fall by at least half. Most dermatologists pair a hormonal therapy with a topical retinoid, and add isotretinoin when acne is severe or scarring. The right choice depends on contraception needs, medical history and pregnancy plans.

Can hormonal acne go away on its own?

Hormonal acne can ease on its own, but adult female acne often persists for years because the underlying androgen sensitivity does not change quickly. Dreno and colleagues (2019) found acne in around 26% of women in their 30s and 12% in their 40s. Breakouts sometimes shift with pregnancy, stopping or starting the pill, and perimenopause. Waiting is reasonable for mild acne; nodules, cysts or scarring are reasons to see a dermatologist rather than wait.

Does diet affect hormonal acne?

Diet affects hormonal acne mainly through insulin and IGF-1, which raise sebum and androgen production. A 12 week randomized trial by Smith and colleagues (2007) found that a low glycemic load diet reduced acne lesion counts and free androgen index compared with a conventional diet. Observational studies also link dairy, especially skim milk, with more acne. Diet changes work best as support for medical treatment, particularly in women with PCOS or insulin resistance.

Can men get hormonal acne?

Men can get hormonally driven acne, most often during puberty, with anabolic steroid use, or when testosterone replacement therapy raises androgen levels and sebum output. The breakouts tend to appear on the face, chest and back rather than following a monthly cycle. Spironolactone and oral contraceptives are not used for acne in men, so treatment relies on topical retinoids, benzoyl peroxide, oral antibiotics, isotretinoin and, for TRT users, adjusting the testosterone dose with the prescriber.

Related Reading

• Acne Treatment Options: From Topicals to Regenerative Therapies
• What Causes Acne? The Science Behind Breakouts
• Severe Acne Treatment: Options Beyond Accutane
• Peptide Injections: What They Are and How They Work
• Red Light Therapy at Home
• Hormonal Acne Treatment: Medical, Topical and Lifestyle Approaches

Sources

1. Dreno B et al. “Acne in women: a real-world study with dermatologist’s evaluation.” Int J Dermatol. 2019;58(3):e37-e38. doi:10.1111/ijd.14176 ↩
2. Deplewski D, Rosenfield RL. “Role of hormones in pilosebaceous unit development.” Endocr Rev. 2000;21(4):363-392. doi:10.1210/edrv.21.4.0404 ↩
3. Thiboutot D, Gilliland K, Light J, Lookingbill D. “Androgen metabolism in sebaceous glands from subjects with and without acne.” Arch Dermatol. 1999;135(9):1041-1045. doi:10.1001/archderm.135.9.1041 ↩
4. Nestler JE. “Metformin for the treatment of the polycystic ovary syndrome.” N Engl J Med. 2008;358(1):47-54. doi:10.1056/NEJMct0707092 ↩
5. Adebamowo CA et al. “High school dietary dairy intake and teenage acne.” J Am Acad Dermatol. 2005;52(2):207-214. doi:10.1016/j.jaad.2004.08.007 ↩
6. Zouboulis CC, Bohm M. “Neuroendocrine regulation of sebocytes: a pathogenetic link between stress and acne.” Exp Dermatol. 2004;13(Suppl 4):31-35. doi:10.1111/j.1600-0625.2004.00254.x ↩
7. Koltun W et al. “Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 microg plus drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis.” Eur J Obstet Gynecol Reprod Biol. 2011;155(2):171-175. doi:10.1016/j.ejogrb.2010.12.027 ↩
8. Charny JW, Choi JK, James WD. “Spironolactone for the treatment of acne in women, a retrospective study of 110 patients.” Int J Womens Dermatol. 2017;3(2):111-115. doi:10.1016/j.ijwd.2016.12.002 ↩
9. Swinnen I, Declercq L, Garmyn M. “Topical androgen receptor antagonist for the treatment of acne and seborrhoea.” Eur J Dermatol. 2007;17(3):227-229. ↩
10. Plovanich M, Weng QY, Mostaghimi A. “Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne.” JAMA Dermatol. 2015;151(9):941-944. doi:10.1001/jamadermatol.2015.0454 ↩
11. Hebert AA et al. “Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials.” JAMA Dermatol. 2020;156(6):621-630. doi:10.1001/jamadermatol.2020.0465 ↩
12. Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA. “The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial.” J Am Acad Dermatol. 2007;57(2):247-256. doi:10.1016/j.jaad.2007.01.046 ↩
13. Zacche MM, Caputo L, Filippis S, Zacche G, Dindelli M, Ferrari A. “Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.” Gynecol Endocrinol. 2009;25(8):508-513. doi:10.1080/09513590903015544 ↩
14. Dreno B et al. “Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris.” Dermatology. 2001;203(2):135-140. doi:10.1159/000051728 ↩
15. Reynolds RV, Yeung H, Cheng CE, et al. “Guidelines of care for the management of acne vulgaris.” J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. doi:10.1016/j.jaad.2023.12.017 ↩